Cannabis may increase the effects of other drugs that cause drowsiness, including:
Additional states continue to undertake or pursue citizen petitions in the future to legalize the recreational use of cannabis. According to the Brookings Institute, Presidential election years bring out an electorate more favorable to cannabis legalization than the off-year electorate. In one survey, two out of every three Americans now support legalization.
The most common uses for medical cannabis include for severe or long-term pain, nausea and vomiting due to chemotherapy (cancer treatments), and painful muscle spasms. However, there are several medical conditions for which patients can use medical marijuana, which can vary by state law:
In the past (for example, in the Obama administration) it has been stated that it is unlikely that the federal government is interested in pursuing individuals complying with state-mandated regulations surrounding legalized cannabis for recreational use, although the CSA law still gives them authority to do so. These rules can and have change based on political changes that may occur in the legislature.
Specific city and county laws have been enacted to regulate how citizens and tourists may possess and consume marijuana. Penalties exist for driving while under the influence of marijuana.
The only known cure is to stop using cannabis completely. Extremely hot showers and topical capsaicin cream have been found to relieve symptoms of CHS, but exactly why this occurs is not known. Antinausea medications are not usually effective for CHS. Stopping the use of marijuana completely will usually relieve symptoms within days or weeks, but it is not known if marijuana consumption can be resumed.
Common or street names: Bud, ganja, grass, hashish, hemp, Indian hemp, marijuana, pot, reefer, weed.
Maas, A. I., Murray, G., Henney, H., III, Kassem, N., Legrand, V., Mangelus, M., Muizelaar, J. P., Stocchetti, N., and Knoller, N. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006;5(1):38-45. View abstract.
Jordan, K., Roila, F., Molassiotis, A., Maranzano, E., Clark-Snow, R. A., and Feyer, P. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009. Support.Care Cancer 2011;19 Suppl 1:S37-S42. View abstract.
Hacke ACM, Lima D, de Costa F, et al. Probing the antioxidant activity of [delta](9)-tetrahydrocannabinol and cannabidiol in Cannabis sativa extracts. Analyst. 2019;144(16):4952-4961. View abstract.
Volicer, L., Stelly, M., Morris, J., McLaughlin, J., and Volicer, B. J. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease. Int.J.Geriatr.Psychiatry 1997;12(9):913-919. View abstract.
Tramer MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001;323:16-21.. View abstract.